Navigation Links
Patients and scientists join forces to tackle Friedreich's Ataxia
Date:11/14/2013

Barcelona, Thursday 14 November 2013.- The Spanish Federation of Ataxia (FEDAES)in representation of the GENEFA Platform for a Friedreich's Ataxia cure, the Babel Family association for biomedical research into Friedreich's Ataxia, the "Centro de Biologa Molecular Severo Ochoa" (CMBSO), and the Institute for Research in Biomedicine (IRB Barcelona) have signed an agreement through which these patients' associations will fund, by means of donations, a 3-year research project addressing Friedreich's Ataxia.

Friedreich's Ataxia is a rare degenerative disease of the nervous system that affects coordination, balance and movement. It is a monogenic disease, that is to say, it is caused by a defect in only one gene. Those affected by this disorder have inherited an altered frataxin gene from both parents. The project aims to develop molecular tools to transport a correct copy of the defective gene to all the cells of the body and particularly to a kind of neuron that undergoes degeneration and causes the disease. This approach seeks to restore the normal levels of frataxin and to stop the manifestation of the degenerative symptoms of the disease.

The GENEFA Platform heads the money-raising campaign to collect the 300,000 euros required to develop this gene therapy project. Juan Carlos Baiges, in representation of FEDAES/GENEFA and the Babel Family for this project, expresses his enthusiasm, "it is the first step towards achieving an effective treatment based on solid basic research knowledge", and adds, "we have a motivating project ahead that may lead us closer to a treatment."

Ernest Giralt, at IRB Barcelona, and Javier Daz-Nido, at CBMSO, scientific co-leaders of the project, stress that, "it is uncommon for basic researchers to have direct contact with patients and this project is fantastic because it reminds us that the solutions to diseases derive from basic research, the cornerstone of future applications."

A SINGLE
'/>"/>

Contact: Sònia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Reproductive health providers should discuss environmental exposure risks with patients
2. Low-calorie diet may be harmful for bowel disease patients
3. Interventional radiology: Mitigating symptoms, improving quality of life of MS patients
4. Interventional radiologists see significant symptom relief in MS patients
5. Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
6. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
7. Obese patients face higher radiation exposure from CT scans -- but new technology can help
8. Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
9. Transcatheter aortic valve implantation shows promise in patients with severe aortic stenosis
10. Urgent research needed to determine most effective follow-up care for lung cancer patients
11. Gene signature helps identify risk of relapse in lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Patients and scientists join forces to tackle Friedreich's Ataxia
(Date:11/21/2014)... Calif. , Nov. 20, 2014   Atmel® ... leader in microcontroller (MCU) and touch technology solutions, today ... temperature sensors with the widest V cc ... higher temperature accuracy and faster I 2 C bus ... and serial EEPROM memory making them ideal for consumer, ...
(Date:11/18/2014)... BOSTON , Nov. 17, 2014   ... HealthCare and EMC collaborate to develop The Partners ... , The Partners Data Lake will allow ... to improve diagnostics, treatment and the lives of ... support research and clinical activities across the Partners ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... years ago, a 71-year-old Indiana man impaled his hand on a ... infection that led scientists to discover a new bacterium and solve ... On Oct. 15, 2010, Thomas Fritz, a retired inventor, engineer and ... his home near Evansville, Ind. As he dragged away the ...
... The question of how life began on a molecular ... mathematical research sheds light on a possible mechanism by which ... that existed on the early Earth. Researchers have proposed ... gotten its start, even before the first genes or living ...
... which are typically only found in fetal development, can become ... can integrate into heart muscle tissue after injection. An ... Although mortality rates are declining, heart attacks are still among ... Often, the cause of a heart attack is the closure ...
Cached Biology News:Microbial 'missing link' discovered after man impales hand on tree branch 2Microbial 'missing link' discovered after man impales hand on tree branch 3Microbial 'missing link' discovered after man impales hand on tree branch 4Model sheds light on the chemistry that sparked the origin of life 2A novel therapeutic advancement in the search for heart muscle progenitor cells 2A novel therapeutic advancement in the search for heart muscle progenitor cells 3A novel therapeutic advancement in the search for heart muscle progenitor cells 4
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ - RepliCel Life Sciences ... medicine company focused on the development of autologous cell ... of the University of Calgary in conjunction with co-authors ... which further validates the company,s ongoing clinical research using ... of pattern baldness. The paper entitled " ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 ... peer-reviewed publication of original research, reviews and editorials ... and clinical practice, today published a provocative article ... the development, progression and potential treatment of prostate ... endocrinology research and proposes the possibility that there ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... Bina Technologies, Inc. (Bina, Redwood ... have been acquired by Roche (SIX: RO, ROG; OTCQX: ... company that provides a big data platform for centralized ... for the academic and translational research markets.  Bina will ... continue to focus on development of their innovative genomic ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... FORT WORTH, Texas, April 14, 2011 The Wound ... forum on dynamic reciprocity at the combined meeting of ... Wound Healing Society (WHS) being held in Dallas at ... 14-17, 2011. Presenting faculty are Dr. Ira M. Herman, ...
... April 14, 2011 Reportlinker.com announces ... is available in its catalogue: ... And Biochips ... Product Development Opportunities and Business Expansion ...
... NEW YORK, April 14, 2011 Reportlinker.com ... is available in its catalogue: ... to 2017 – Neurostimulation Devices, Interventional Neurology ... China-to-2017-–-Neurostimulation-Devices-Interventional-Neurology-and-Other.html Neurology Devices Market Outlook ...
Cached Biology Technology:The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 2The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 3The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 4Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips 2Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips 3Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 2Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 3Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 4Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 5Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 6Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 7Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 8Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 9Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 10Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 11Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 12Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 13
Zonula Adherens Sampler Kit 10 mu g each...
Purified anti-SOCS3...
Tumor Suppressor Sampler Kit 10 mu g each...
AMAP Multi Site-directed Mutagenesis Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: dry ice...
Biology Products: